Tag Archives: China

Fixing Biotech's Broken Business Model

Despite some notable successes, the global biotech industry has fallen short of expectations. Strategic collaborations have been on the increase, but there is now a need for more co-operation using new collaboration models, writes Jo Pisani. The current business model on which biotech has relied is flawed. Due to poor rates of return, investment has […]
Posted in Biotech, Deals, Emerging Markets, Europe, Global, Guest Blog, R&D | Also tagged , , , , , , , | Leave a comment

Drug Payment Reform in China: Now That's a Mass Market

The task of building drug access for one billion new customers in China is probably this decade’s grandest public policy experiment.  It is taking place largely behind the scene in a series of often tense exchanges between Beijing and local governments – the dialogue is worth watching for the long-term commercial implications in what all […]
Posted in Emerging Markets, Global, Strategy | Also tagged , , | Leave a comment

US and Europe At Risk from Substandard Medicines

Guest blog by Helen Disney, Chief Executive and Founder of the Stockholm Network, a pan-European think tank. When most of us look at taking a new medicine we tend to think it will make us better. Some of us may think about possible side effects but few of us expect the medicines we take to […]
Posted in Biotech, Emerging Markets, Europe, Global, Guest Blog, Regulatory, Safety | Also tagged , , , , , , , , , , | Leave a comment

Working Towards a Solution : An Interview with Oracle’s Neil de Crescenzo

Just a few days shy of the one year anniversary of the launch of Oracle’s Health Sciences Global Business Unit, Neil de Crescenzo, senior vice president and general manager for the business unit sat down with Pharm Exec to talk about the future of clinical trial software and technology and the need for standards and […]
Posted in People, Strategy, Technology | Also tagged , , , , , , , | 2 Comments

The Real China Strategy

There’s a lot of talk these days about India and China as potential markets and as sources for cheap manufacturing and R&D. But the real potential of these countries is far more interesting: As China and India (and Brazil, Russia, and Korea) learn to create new products, they’re going to do it at price points […]
Posted in Biotech, Deals, Emerging Markets, Strategy | Also tagged , , , , | 10 Comments
  • Categories

  • Meta